Related Experiment Video
Updated: Sep 19, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Population Incidence and Burden of Juvenile Idiopathic Arthritis on Australian Health System: Data Linkage Study
S J Lain1,2, L Ivancic1,2, J Chaitow3,4
1Child Population and Translational Health Research, Faculty of Medicine and Health, The University of Sydney, Australia.
Insights
Children with juvenile idiopathic arthritis (JIA) frequently use health services, with increased hospital and outpatient visits before and after their first JIA admission. This highlights JIA's significant impact on pediatric healthcare utilization and costs.
Area of Science:
- Pediatric Rheumatology
- Health Services Research
- Public Health
Background:
- Juvenile idiopathic arthritis (JIA) is a chronic condition affecting children.
- Population-based data on healthcare utilization for pediatric JIA is limited.
- Understanding healthcare patterns is crucial for resource allocation and patient management.
Purpose of the Study:
- To determine the population incidence of health service utilization among children with JIA.
- To analyze healthcare patterns and associated costs in the year preceding and following the first JIA hospital admission.
- To quantify the impact of JIA on the healthcare system.
Main Methods:
- A population-based data linkage study was conducted in New South Wales, Australia (2002-2019).
- Included children under 16 years with a first hospital diagnosis of JIA.
- Linked hospital admission, emergency department (ED), and outpatient datasets were used to assess health service utilization and costs.
Main Results:
- 1433 children were hospitalized with a first JIA diagnosis; peak incidence was 7.2/100,000 children annually.
- In the year prior to first admission, 29% were hospitalized, 43% visited ED, and 48% attended outpatient clinics.
- Post-admission, 44% had inpatient stays, 61% attended outpatient clinics, and costs rose from $4422 to $11,806 per child annually.
Conclusions:
- Children with JIA are significant users of hospital services.
- Healthcare utilization, particularly inpatient and outpatient visits, increases substantially around the first JIA admission.
- JIA imposes a considerable burden on both affected children and the healthcare system.
Aim:
There is a lack of population-based information on patterns of healthcare for children with juvenile idiopathic arthritis (JIA). The aim of this study was to examine the population incidence of health service utilisation for children with JIA.
Methods:
We conducted a population-based data linkage study that examined children aged < 16 admitted to hospital with a diagnosis of JIA in New South Wales, Australia between 2002 and 2019. The annual incidence of JIA hospitalisations was calculated using population denominators. Health service utilisation and associated costs to the health system 12 months before and after the first JIA admission were examined using linked hospital admission, emergency department (ED) and outpatient datasets.
Results:
A total of 1433 children were admitted to hospital with a first diagnosis of JIA; the highest annual incidence was 7.2/100 000 children. In the year before the first JIA admission, 29% were admitted to hospital, 43% presented to the ED and 48% attended an outpatient clinic. In the year following the first JIA admission, inpatient/outpatient attendance increased: 44% had at least one inpatient admission, 61% attended ≥ 1 outpatient clinics. ED presentations remained stable. The unadjusted total cost to the health system in the year before the first JIA admission was $4422 per child diagnosed with JIA compared to $11 806 in the year following the first JIA admission.
Conclusion:
Children with JIA have been demonstrated to be frequent users of hospital services, particularly just before and following their first admission for JIA, highlighting the impact of JIA both on the child and the health system.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Principles of Disease Surveillance
Rheumatic Heart Disease I: Introduction

